Clinical and immunological risk factors associated with haemophilus influenzae type b conjugate vaccine failure in childhood

Clinical Infectious Diseases

Volumn 31, Issue 4, 2000, Pages 973-980

  Heath, P T ^a   Booy, R ^a   Griffiths, H ^a   Clutterbuck, E ^a   Azzopardi, H J ^a   Slack, M P E ^a   Fogarty, J ^a   Moloney, A C ^a   Moxon, E R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHILD; DOSE RESPONSE; DRUG EFFICACY; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE;

ADOLESCENT; AGE FACTORS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; IRELAND; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; VACCINES, CONJUGATE;

EID: 0034451944     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318132     Document Type: Article

References (32)

1. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland
2. Epidemiological impact of conjugate vaccines on invasive disease caused by Haemophilus influenzae type b
3. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease
4. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia
5. Polysaccharide conjugate vaccine responses in bone marrow transplant patients
6. The biology of Haemophilus influenzae type b vaccination failure
7. Failures after immunization with Haemophilus influenzae type b vaccines: 1991-1995
8. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants
9. Haemophilus influenzae type b meningitis in a fully immunized child with a cerebrospinal fluid shunt
10. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine
11. PCR for capsular typing of Haemophilus influenzae
12. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule
13. Antibody persistence alter accelerated immunisation against Haemophilus influenzae type b
14. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants
15. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants
16. Three-year follow-up of vaccine response in extremely preterm infants
17. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine
18. The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland
19. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome
20. Abnormal serum IgG subclass pattern in children with Down's syndrome
21. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine
22. Cyclic neutropenia: A clinical review
23. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants
24. Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction
25. Immunoglobulin deficiency syndromes and therapy
26. Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis
27. Advisory Committee on Immunization Practices update: Report of PedvaxHIB lots with questionable immunogenicity
28. The acquisition of antipneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK
29. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections
30. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91)
31. Haemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine